These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 5941178)

  • 1. Immunological studies with group B arthropod-borne viruses. VI. Hemagglutination-inhibiting antibody responses to 17D yellow fever vaccine in human subjects with different degrees of complexity of pre-vaccination group B virus experience.
    Hatgi JN; Wisseman CL; Rosenzweig EC; Harrington BR; Kitaoka M
    Am J Trop Med Hyg; 1966 Jul; 15(4):601-10. PubMed ID: 5941178
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological studies with group B arthropod-borne viruses. V. Evaluation of cross-immunity against type 1 dengue fever in human subjects convalescent from subclinical natural Japanese encephalitis virus infection and vaccinated with 17D strain yellow fever vaccine.
    Wisseman CL; Kitaoka M; Tamiya T
    Am J Trop Med Hyg; 1966 Jul; 15(4):588-600. PubMed ID: 4287392
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological studies with group B arthropod-borne viruses. IV. Persistence of yellow fever antibodies following vaccination with 17D strain yellow fever vaccine.
    ROSENZWEIG EC; BABIONE RW; WISSEMAN CL
    Am J Trop Med Hyg; 1963 Mar; 12():230-5. PubMed ID: 13975014
    [No Abstract]   [Full Text] [Related]  

  • 4. [The inhibiting effect of anticholera vaccination carried out simultaneously or at short intervals on yellow fever immunization. Is it real or assumed? Results of a retrospective study].
    Poveda JD; Raccurt CP; Le Fur R; M'Bailara L; Malvy JM; Le Bras M; Saliou P; Fleury HJ
    Bull Soc Pathol Exot; 1990; 83(4):529-35; discussion 535-6. PubMed ID: 2286006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Survey with human sera from West Cameroon (author's transl)].
    Radda A
    Zentralbl Bakteriol Orig A; 1973 Dec; 225(2):375-80. PubMed ID: 4150072
    [No Abstract]   [Full Text] [Related]  

  • 6. Neutralizing and haemagglutination-inhibiting antibodies to yellow fever 17 years after vaccination with 17D vaccine.
    GROOT H; RIBERIRO RB
    Bull World Health Organ; 1962; 27(6):699-707. PubMed ID: 13950710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of the complement-fixation test for distinguishing naturally acquired from vaccine-induced yellow fever infection in flavivirus-hyperendemic areas.
    Monath TP; Craven RB; Muth DJ; Trautt CJ; Calisher CH; Fitzgerald SA
    Am J Trop Med Hyg; 1980 Jul; 29(4):624-34. PubMed ID: 7406113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological reactions in Rhesus monkeys inoculated with the 17D strain of yellow fever virus.
    GROOT H
    Bull World Health Organ; 1962; 27(6):709-15. PubMed ID: 13950709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of hemagglutination-inhibiting antibodies to arboviruses in sera of young individuals in the Federal Republic of Germany and in the Republic of Togo (West Africa)].
    Ebke J; Schäfer E
    Zentralbl Bakteriol Orig A; 1971 Oct; 218(2):149-59. PubMed ID: 4403535
    [No Abstract]   [Full Text] [Related]  

  • 10. Yellow fever outbreak in Ipetu-Ijesa: response after mass vaccination.
    Adu FD; Adeniji JA; Tomori O; Adelasoye A
    Rev Roum Virol; 1993; 44(1-2):3-7. PubMed ID: 8043476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential immunization procedure against Group B arboviruses using living attenuated 17D yellow fever virus, living attenuated Langat E5 virus, and living attenuated dengue 2 virus (New Guinea C isolate).
    Price WH; Casals J; Thind I; O'Leary W
    Am J Trop Med Hyg; 1973 Jul; 22(4):509-23. PubMed ID: 4352231
    [No Abstract]   [Full Text] [Related]  

  • 12. Research on dengue in tissue culture. IV. Serologic responses of human beings to combined inoculations of attenuated, tissue-cultured type I dengue virus and yellow fever vaccine.
    Fujita N; Oda K; Yasui Y; Hotta S
    Kobe J Med Sci; 1969 Dec; 15(4):163-80. PubMed ID: 4317037
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: characterization with human monoclonal antibody fragments and neutralization escape variants.
    Daffis S; Kontermann RE; Korimbocus J; Zeller H; Klenk HD; Ter Meulen J
    Virology; 2005 Jul; 337(2):262-72. PubMed ID: 15919103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arboviruses and lemurs in Madagascar: experimental infection of Lemur fulvus with attenuated strains of yellow fever virus].
    Rodhain F
    Bull Soc Pathol Exot Filiales; 1984; 77(3):255-62. PubMed ID: 6488418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA.
    Niedrig M; Lademann M; Emmerich P; Lafrenz M
    Trop Med Int Health; 1999 Dec; 4(12):867-71. PubMed ID: 10632996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1987 yellow fever epidemics in Oyo State, Nigeria: a survey for yellow fever virus haemagglutination inhibiting antibody in residents of two communities before and after the epidemics.
    Olaleye OD; Omilabu SA; Faseru O; Fagbami AH
    Virologie; 1988; 39(4):261-6. PubMed ID: 2851207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of dogs to St. Louis encephalitis and other selected arthropod-borne viruses.
    Furumoto HH
    Am J Vet Res; 1969 Aug; 30(8):1371-80. PubMed ID: 5816366
    [No Abstract]   [Full Text] [Related]  

  • 18. Yellow fever vaccine. V. Antibody response in maonkeys inoculated with graded doses of the 17D vaccine.
    Mason RA; Tauraso NM; Ginn RK; O'Brien TC; Trimmer RW
    Appl Microbiol; 1972 May; 23(5):908-13. PubMed ID: 4624211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program.
    Collaborative Group for Studies with Yellow Fever Vaccine
    Vaccine; 2007 Apr; 25(16):3118-23. PubMed ID: 17316925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definitive efficacy and safety testing for equine encephalomyelitis vaccine.
    Hays MB
    J Am Vet Med Assoc; 1969 Jul; 155(2):374-6. PubMed ID: 5816120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.